We delve into the emerging domain of drug development, using psychoactive molecules to combat Alcohol Use Disorder (AUD). Explore how these therapeutic candidates, engineered from psychoactive molecules, have the potential to reshape AUD treatments by offering safer and potentially more effective solutions. This discussion promises to unveil the pioneering methods involved in the development of these compounds and their potential impact on the landscape of AUD treatment.